Grant: Discovery Grants Program - Individual
University of Waterloo
$28,020.00
Cellular mechanisms of material-associated thrombosis
EF 2008-09
Résumé
While cardiovascular devices have significantly increased the life expectancy of millions of people, their use is not without complications. Despite anticoagulant and anti-platelet therapies, blood clots (thrombus) continue to occur with cardiovascular devices such as stents and heart valves. The consequences may be fatal and the cost to treat these thrombotic complications is significant. While most research on thrombus formation has ignored the role of white blood cells (leukocytes), my own research has shown that they may have a significant impact. Using in vitro experiments, whereby blood contacts materials used in mechanical heart valves and stents, this research will examine in more details the role that leukocytes play in thrombus formation in the presence of a material. Particular emphasis will be placed on the interactions between the material, leukocytes and other components of blood such as platelets. This is a holistic approach which will identify interactions that are often overlooked. As a result, this will identify potential target for drug therapies and surface modifications that effectively reduce the incidence of thrombus formation with cardiovascular devices.
This research will train four graduate students in the interdisciplinary methods of biomaterials engineering, preparing them to contribute to the emerging Canadian biotechnology industry. Overall, this research will provide a greater understanding of blood-material interactions and help in the development of materials that are better accepted by the human body. Better materials will translate into fewer complications with the use of cardiovascular devices, hence improving the quality of life of patients and reducing re-hospitalization costs.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
341512-2007
Name nom
Gorbet, Maud
Department département
Systems Design Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
28020
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
2
Nb partie
4
Application title
Cellular mechanisms of material-associated thrombosis
Keyword
NA
Application summary
While cardiovascular devices have significantly increased the life expectancy of millions of people, their use is not without complications. Despite anticoagulant and anti-platelet therapies, blood clots (thrombus) continue to occur with cardiovascular devices such as stents and heart valves. The consequences may be fatal and the cost to treat these thrombotic complications is significant. While most research on thrombus formation has ignored the role of white blood cells (leukocytes), my own research has shown that they may have a significant impact. Using in vitro experiments, whereby blood contacts materials used in mechanical heart valves and stents, this research will examine in more details the role that leukocytes play in thrombus formation in the presence of a material. Particular emphasis will be placed on the interactions between the material, leukocytes and other components of blood such as platelets. This is a holistic approach which will identify interactions that are often overlooked. As a result, this will identify potential target for drug therapies and surface modifications that effectively reduce the incidence of thrombus formation with cardiovascular devices.
This research will train four graduate students in the interdisciplinary methods of biomaterials engineering, preparing them to contribute to the emerging Canadian biotechnology industry. Overall, this research will provide a greater understanding of blood-material interactions and help in the development of materials that are better accepted by the human body. Better materials will translate into fewer complications with the use of cardiovascular devices, hence improving the quality of life of patients and reducing re-hospitalization costs.